Strategic Information Management System (SIMS) Data Definition

Transcription

1 Strategic Information Management System (SIMS) Data Definition For Sexually Transmitted Infections (STI) and Reproductive Tract Infections (RTI) National Aids Control Organisations India s Voice against AIDS Department of AIDS Control Ministry of Health & Family Welfare, Government of India

2 CONTENTS 1. Introduction 3 2. Monthly Report Format for STI/RTI Clinics (all public health facilities 4 supported by NACO and TI NGOs) 3. Guidelines for filling Monthly Report Format for STI/RTI Clinics (all public 8 health facilities supported by NACO and TI NGOs) i. Section 1: No. of Patients availed STI/RTI services in this month 9 ii. Section 2: STI/RTI Syndromic Diagnosis 10 iii. Section 3: Details of Other Services provided to patients attending 11 STI/RTI clinics in this month iv. Section 4: STI/RTI service for HRGs in the month 12 v. Section 5: ANC syphilis screening in this month 13 vi. Section 6: Laboratory diagnosis of STI/RTI 13 vii. Section 7: Drugs and Consumables 15 viii. Section 8: Details of staff at the STI/RTI clinics Simplified STI/RTI Monthly reporting format Guidelines for filling Monthly reporting format from NRHM facilities (all public 18 health facilities not supported by NACO) i. ii. iii. iv. Section 1: No. of Patients Availed STI/RTI services in this month 19 Section 2: Syndromic diagnosis and investigation details 19 Section 3: Details of syphilis screening of pregnant women 21 Section 4: Status of Drugs & test kits Reporting Format of Regional STI Training, Research and Reference 22 Laboratories 7. Guidelines for filling reporting format for Regional STI Training, Research and 26 Reference Laboratories I. II. III. IV. V. VI. Section 1 A Age and sex distribution of STI/RTI Patients/Samples 27 received from within the state including facilities in the same premises Section 1 B Age and sex distribution of STI/RTI Patients/ Samples 27 received from linked States Section 2 Syndromic validation of Patient/Sample received by centre. 28 Section 3 Number of Gonococci cultures and Anti microbial resistance 28 studies performed Section 4 Number of Other STI/RTI pathogen cultured and Anti 28 microbial resistance studies performed Section 5 Status of kits 29 VII. Section 6 Annual Maintenance Status of equipment 29 VIII. Section 7 Details of Trainings conducted 29 IX. X. Section 8 Details of Syphilis EQAS of conducted 29 Section 9 Details of STI/RTI research work conducted by the centre 30

3 STI/RTI INTRODUCTION Prevention and control of sexually transmitted infections (STI) and reproductive tract infections (RTI) is one of the cost effective approach in halting and reversing the HIV epidemic progression. NACO under NACP envisages treating 1.5 crore STI/RTI episodes and providing standardized STI/RTI services at all levels including sub district facilities and through identified preferred providers in private sector. STI/RTI if not treated early and correctly may cause serious consequences that include infertility, pelvic inflammatory disease, cervical cancer and adverse pregnancy outcomes. The STI including reproductive tract infections prevalence is estimated to be 6 % in India and accordingly an estimated 3crore persons may be affected with STI/RTIs annually. STI/RTI is a major public health problem and adversely affects the reproductive health and cause suffering for both men and women; their consequences are far more devastating and widespread among women than among men. STI/RTI can be prevented and controlled by practicing safer sex, by limiting the number of sexual partners and by using condoms correctly and consistently at every sexual act. There are three reporting formats for STI/RTI programme: 1. Monthly report format for STI/RTI clinics (all public health facilities supported by NACO and TI NGOs) 2. Simplified STI/RTI monthly reporting format for public/private sector health facilities 3. Reporting Format for Regional STI Training, Research and Reference Laboratories 3

4 Monthly Report Format for STI/RTI Clinics (all public health facilities supported by NACO and TI NGOs) Monthly STI/RTI Unique ID. No. of STI/RTI Clinic /Gynae OPD /TI NGO MONTHLY REPORT FORMAT FOR STI/RTI CLINICS Name of STI/RTI Clinic/ Hospital to which the Gynaecology OPD is Attached/ TI NGO Sub Type Category Location Address : District : Block : City : Reporting Period : Month(MM): Year(YYYY): Name of Officer In-charge : Phone no. of Officer In-charge : Name of Centre/service provider : Type of Patients Section 1 : No. of Patients Availed STI/RTI services in this month Age Group & Sex Total Up to & above Male Fe m ale TS/TG Male Female TS/TG Male Female TS/TG Male Female TS/TG Male Female TS/TG Clinic visit with STI/RTI complaint and were diagnosed with an STI/RTI Clinic visit with STI/RTI complaint but were NOT diagnosed with an STI/RTI. Clinic visit for Syphilis Screening (Excluding ANC) For TI-NGOs-RMC, PT, Syphilis Screening (whichever applicable) Follow up visit for the index STI/RTI complaint Total No of visits

5 Section 2 : STI syndromic diagnosis (Should be filled by all STI/RTI service providers for first clinic visit only) Age Group & Sex Diagnosis Male Female TS/TG Total 1. Vaginal/ Cervical Discharge (VCD) 0 2. Genital Ulcer (GUD)-non herpetic 0 3. Genital ulcer (GUD) herpetic 0 4. Lower abdominal pain (LAP) 0 5. Urethral discharge (UD) 0 6. Ano-rectal discharge (ARD) 0 7. Inguinal Bubo (IB) 0 8. Painful scrotal swelling (SS) 0 9. Genital warts Other STIs Serologically +ve for syphilis 0 Total No of episodes No of people living with HIV (PLHIVs) who attended with STI/RTI complaint during the month Section 3. Details of other services provided to patients attending STI/RTI clinics in this month (To be filled in by all STI/RTI Service Providers) Service Male Female TS/TG Total 1. Number of patients counseled 0 2. Number of condoms provided 3. Number of RPR/VDRL tests conducted 4. Number of patients found reactive 0 5. Number of partner notification undertaken 0 6. Number of partners managed 0 7. Number of patients referred to ICTC 0 8. Number of patients found HIV-infected (of above) 0 9. Number of patients referred to other services

6 Section 4 : STI/RTI service for HRGs in this month (To be filled in by TI NGO) Male Female TS/TG Total Number of new individuals visited the clinic 0 Number of Presumptive Treatments(PT) provided for gonococcus and chlamydia 0 N umber of regular STI check-ups(rmc) conducted (check-up including internal examination 0 of HRGs ones in are quarter) Section 5 : ANC syphilis screening in this month (Should be filled by all service providers with ANC service provision) Total Number of ANC first visits in the month (Registration) Number of rapid plasma reagin RPR/VDRL tests performed Number of RPR/VDRL reactive (Qualitative) Number of RPR/VDRL reactive above >=1:8 (Quantitative) Number of pregnant women treated for syphilis Laboratory diagnosis/tests Section 6 : Laboratory diagnosis of STI/RTI (To be filled in by NACO designated STI/RTI clinics with lab/linked to lab) Male Female TS/TG Total 1. Total RPR/VDRL tests performed 0 RPR tests reactive >= 1: Total Gram stain performed 0 Gonococcus + (gram negative intracellular diplococci +) 0 Non-Gonococcus urethritis (NGU)-Pus cells +ve 0 Non-Gonococcus cervicitis (NGC)-Pus cells +ve 0 None 0 Nugents score +ve 0 3. Wet mount test performed 0 Motile Trichomonads +ve 0 Whiff test +ve 0 Clues cells + 0 None 0 4. KOH test performed 0 Candidiasis 0 None 0 6

7 5. Availability of consumables Do you have STI pre-packed kits? Functional Computer Yes/No Yes/No AMC of Computer Yes/No Drugs & Consumables Opening stock Section 7 : Drugs & Consumables Number received this month Consumed Damage/Wastage Closing stock Stock Sufficient for approx months Earliest Expiry Date (Month/Year) Quantity RPR tests 0 0 TPHA kits (wherever applicable) (Tests) 0 0 Prepacked STI Kit Prepacked STI Kit Prepacked STI Kit Prepacked STI Kit Prepacked STI Kit Prepacked STI Kit Prepacked STI Kit Condom Pieces 0 0 Reagent for gram stain 0 0 Reagents for wet mount and KOH test 0 0 Others 0 0 Section 8 : Details of Staff at the STI/RTI or Gynaecology clinics Human resource details at STI/RTI clinics (Should be filled by all STI/RTI clinics) Staff Category Number Sanctioned Number in place Medical Officer Staff Nurse Laboratory Technician Counselor Number of Personnel Trained during month Induction Refresher Others 7

8 Guidelines for filling Monthly Report Format for STI/RTI Clinics (all public health facilities supported by NACO and TI NGOs) Who should fill this? This reporting format should be filled by all STI/RTI service providers and sent to the corresponding reporting authority by the 5th of next month through SIMS. The STI/RTI service providers include: Providers at all designated STI/RTI clinics (located in area/district hospitals, teaching hospitals attached to medical colleges etc) Targeted Interventions providing STI/RTI services for High Risk Behaviour Groups What are the different sections of STI format? The format is divided into eight sections as follows. Section 1: Number of Patients availed STI/RTI services in this month Section 2: STI/RTI syndromic diagnosis Section 3: Details of other services provided to patients attending STI/RTI clinics in this month Section 4: STI/RTI service for HRGs in the month Section 5: ANC Syphilis screening in this month Section 6: Laboratory diagnosis of STI/RTI Section 7: Drugs & Consumables Section 8: Details of Staff at the STI/RTI clinics What should be reported? Section 1, 2, 3, 5, 7 and 8 should be reported by all NACO designated STI/RTI clinics Section 1, 2, 3, 4 and 7 should be filled by all Targeted Interventions Additional Section 6 should be filled up by NACO designated STI/RTI clinics also having laboratory services (Laboratory may be located in the STI/RTI clinic or through linkage with existing laboratory in the hospital) General information: Unique ID. No. of STI/RTI Clinic /Gynae OPD /TI NGO Name of the STI/RTI Clinic/ Hospital to which the Gynaecology OPD is Attached /TI NGO Address of STI/Gynae Explanation Unique ID provided to STI/RTI Clinic /Gynae OPD /TI NGO by respective SACS Name of the institution where STI/RTI Clinic/Gynaecology OPD is located Name of the TI NGO Address of STI clinic including state, city, district, Block/Mandal and pin code 8

9 Reporting period Name and phone number of the Officer in-charge Phone number of the Officer in-charge Explanation Reporting month and year in the form of MM and YYYY. Example: the data for the month January, 2010 would be reported in Feb So the reporting month is 01 and year is Name of the medical officer who is in charge of STI Clinic Phone number of the officer who is in charge of STI Clinic Section 1: No. of Patients availed STI/RTI services in this month Should be reported by all STI/RTI service providers One individual should be entered once in a month in this section in any row Fill the number of individuals who have availed STI/RTI services under appropriate age and sex category Fill in the total number of STI/RTI visits under the specific category as per description below Explanation Clinic visit with STI/RTI complaints and were diagnosed with an STI/RTI Clinic visit with STI/RTI complaint but were NOT diagnosed with an STI/RTI Clinic visit for syphilis screening (Exclude ANC) For TI-NGOs-RMC, PT, Syphilis Screening (whichever applicable) Fill the number of individuals visited with any STI/RTI complaints as per STI/RTI patient wise card and was treated for the same. This indicates fresh STI/RTI episodes*. Fill the number of individuals visited for complaints of STI/RTI, but were not diagnosed with STI/RTI as per patient wise card. Include the patients who came for syphilis screening to Designated STI/RTI clinics. Do not include ANC attendees. Only for TI-NGOs, fill all those HRG (without diagnosed STI/RTI) attending the STI clinic for Regular Medical Check-up, Presumptive Treatment and Syphilis screening*. *1. If any HRG attending for RMC or syphilis screening or PT is found to be having STI/RTI, they should be entered in row 1 only. 2. If any HRG availing more than 1 service (eg RMC+Syphilis screening, PT + syphilis screening, Symptomatic STI + Syphilis screening) should be entered only once in one row based on his having an STI/RTI or not. 9

10 Follow up visits for the index STI/RTI complaint Age group and Sex Total no. of visits Explanation Fill the number of patients who have come for a follow up visit (within 14 days of availing treatment) out of patients counted in row 1 (clinic visit with STI/RTI and were diagnosed with STI/RTI). If a patient visits the clinic after 14 days with or without the same STI/RTI complaint, s/he will be counted in row 1. Fill the number of individual availed STI/RTI services under appropriate age (up to 19, 20-24, 25-44, 45 & above) and sex category. This is auto calculated in software. The total gives total attendance of individuals at STI/RTI Clinic. Section 2: STI/RTI Syndromic Diagnosis Should be reported by all STI/RTI service providers Should be filled for clinic visit with STI/RTI complaints and were diagnosed with STI/RTI only (Section 1 Row 1) Diagnosis could be reached on syndromic/clinical/etiological basis Fill up consolidated number of STI/RTI patients diagnosed with following syndromes Sl No Vaginal/Cervical discharge (VCD) Genital ulcer disease (GUD)-Non Herpetic Genital ulcer disease (GUD)-Herpetic a) Woman with symptomatic vaginal discharge b) Asymptomatic patient with vaginal discharge seen on speculum examination c) Cervical discharge seen on speculum examination (All syndromic, etiological and clinical STI/RTI diagnosis relating to vaginal or cervical discharge should be included here). Female or male or transgender with genital or anorectal ulceration and with NO blisters (vesicles). (All STI syndromic, clinical or etiological diagnosis relating to genial ulcers caused by Treponema Pallidum (syphilis), Haemophilus Ducreyi (Chancroid), Granuloma Inguinale and Lymphogranuloma Venereum (LGV) except herpes simplex virus type 2 should be included here). Female or male or transgender with genital or anorectal blisters (vesicles) with ulcers or recurrence primarily caused by herpes simplex virus type 2. 10

11 Sl No Lower abdominal pain (LAP) Urethral discharge (UD) Ano-rectal discharge (ARD) Inguinal Bubo (IB) Painful scrotal swelling (SS) Genital warts Other STIs Serologically +ve for syphilis Total number of episodes No of people living with HIV/AIDS (PLHAs) who attended with STI/RTI complaint during the month Female with lower abdominal pain or tenderness, or cervical motion tenderness. Male or transgender with intact genitalia with Urethral Discharge with or without dysuria or other symptoms. Male, female or transgender with symptoms of tenesmus or if ano-rectal discharge seen on exam. Individuals with inguinal bubo and NO genital ulcer (Syndromic or Clinical diagnosis of LGV should be included here). Male or transgender (with intact genitalia) with painful scrotal swelling (primarily caused by infection of Gonococci and Chlamydia). Individuals with anal or genital warts. Individuals attending with any other STI/RTI related condition (e.g. Genital Scabies, pubic lice, and Genital Molluscum Contagiosum etc). Asymptomatic individuals found serologically positive and treated for syphilis. These counts the total number of episodes of STI/RTI diagnosis made during the month. This is auto calculated in the software. People living with HIV/AIDS diagnosed and treated for STI/RTI. Section 3: Details of Other Services provided to patients attending STI/RTI clinics in this month Should be reported by all STI/RTI service providers Should be filled with details of other services like counselling, condom distribution, referrals provided to STI/RTI clinic attendees as per Section 1 Should be filled separately for male, female and TS/TG Sl No Number of patients counseled Number of condoms provided Number of RPR/VDRL tests conducted Fill total number of STI/RTI clinic attendees provided with STI/RTI counseling. Fill total number of condoms provided to all STI/RTI clinic attendees. Fill total number of RPR/VDRL tests conducted for STI/RTI clinic attendees. 11

12 Sl No Number of patients found reactive Number of partner notification undertaken Number of partners managed Number of patients referred to ICTC Number of patients found HIV-infected (of above) Number of patients referred to other services Fill the number detected reactive for RPR/VDRL test of the above. Fill the total number of partner notifications undertaken of index STI/RTI patients treated. Fill the total number of partners of index STI/RTI patients attended the clinic and managed. Fill the number of STI/RTI clinic attendees referred to ICTC. Fill the number detected as HIV reactive, of the above. Fill in the number of STI/RTI clinic attendees referred for any other services like care and support, tuberculosis screening etc. Section 4: STI/RTI service for HRGs in the month Should be filled by TI-NGO providing services to high risk behavior group (HRG). Number of new individuals visited the clinic Number of presumptive treatment (PT) provided for Gonococcus and Chlamydia Number of regular STI check-ups (RMC) conducted Fill in total number of new High Risk Behaviour Group individuals visiting the clinic for the first time for any clinical services. This would include both symptomatic and asymptomatic HRGs. It has no relationship with what package of services is being availed. This number can be arrived by summing up new clients checked as Yes in patient wise card. Definition of new HRG individual is as per TI guidelines. Fill in total number of HRG individuals (FSW, MSM including TS/TG) who attended the clinic for STI/RTI services without being symptomatic and were provided with treatment for Gonococcus and Chlamydia as per NACO STI/RTI technical guidelines August Fill in the number of HRG individuals (FSW, MSM including TS/TG) who attended the clinic for STI/RTI services without being symptomatic and received RMC. RMC means medical check-up including internal examination of HRG to be done once in a quarter, which may include speculum or proctoscope examination; and found to be not having STI/RTI. Exclude the numbers of HRG receiving presumptive treatment in this row. 12

13 Section 5: ANC syphilis screening in this month Should be filled by all NACO designated STI/RTI clinics Data should be drawn from the records of ANC clinic in the hospital Should fill information for women making first visit for ANC only Number of ANC first visits in the month (Registration) Number of RPR/VDRL tests performed Number of RPR/VDRL tests reactive (qualitative) Number of RPR/VDRL tests reactive >= 1:8 (quantitative) Number of pregnant women treated for syphilis Write the number of pregnant women registered for first time with the ANC clinic during the month. Write the number of registered pregnant women undergone RPR/VDRL test during the month*. Write the number of pregnant women found reactive for RPR/VDRL test*, of the above. Write the number of pregnant women whose RPR/VDRL test* titre is >=1:8, of the above. Write the number of pregnant women diagnosed having syphilis undergone treatment. Section 6: Laboratory diagnosis of STI/RTI Should be filled by all NACO designated STI/RTI clinics Do not include ANC syphilis screening data in this section Sl No 1 2 Total RPR/VDRL test performed RPR test reactive >= 1:8 Total Gram stain performed Number of Smears +ve for Gonococcus Criteria for urethral smear Criteria for endocervical smear Fill in the total number of RPR or VDRL qualitative tests conducted among men, women, and others during the reporting month (write the same number as recorded in row 3 under section 3) Fill in the number of RPR/VDRL tests reactive at or above 1:8 titres among men, women and others*, of the above Fill in total number of gram stain performed among men (urethral smear) and women (endo-cervical smear and vaginal discharge smear)* Fill in number of gram stained smears positive for gonococcus >5 PMN/hpf and intracellular gram negative diplococci inside poly morphonuclear cells Numerous PMN/hpf and intracellular gram negative diplococci inside poly morphonuclear cells 13

14 Sl No Non Gonococcal Urethritis/cervicitis-Pus cells + Criteria for urethral smear Criteria for endocervical smears None Criteria for urethral smear Criteria for endocervical smear Number of smears +ve for Nugent's score Wet mount tests performed Motile trichomonads + Whiff test + Clues cells + None KOH test performed Candidiasis+ None Availability of consumables, functional computers and AMC of Computers Fill in number of gram stained smears positive for non gonococcal urethritis/cervicitis >5 PMN/hpf and NO intracellular gram negative diplococci inside poly morphonuclear cells >10 PMN/hpf and NO gram negative diplococci inside poly morphonuclear cells Fill in number of gram stained smears negative for both < 5PMN/hpf and NO intracellular gram negative diplococci inside poly morphonuclear cells <10 PMN/hpf and NO gram negative diplococci inside poly morphonuclear cells Fill in the number of smears +ve for Nugent's score. Nugent's score is +ve when the score is between 7 to 10 Fill in the total number of wet mounts performed among women Fill in the number of wet mounts demonstrated Motile trichomonads seen under light microscope (10x) Fill in the number of wet mounts released fishy odours of amines, when a drop of 10% potassium hydroxide is placed on vaginal secretion on a glass slide Fill in the number of wet mounts demonstrated Clue_cells in more than 20% of all epithelial cells in any view under light microscope None of the above tests are positive Fill in total number of KOH tests performed among women Fill in the number of KOH slides demonstrated budding yeast/hyphae under light microscope Fill in the number of KOH slides not demonstrated budding yeast/hype under light microscope Check yes or no for availability of the STI/RTI colour coded drug kits, functional computers and its AMC. * The information on number of test conducted and /or results may or may not be available with facility providing clinical services. The providers are to ensure collection of the laboratory data from the concerned providers/ departments/or facilities (microbiology/pathology/general lab).

15 Section 7: Drugs and Consumables Should be filled by all service providers at STI/RTI clinic Provide details of stock of RPR test, TPHA tests kits, Per-packed STI kit 1, kit 2, kit 3, kit 4, kit 5, kit 6 and kit 7, condom pieces, reagents for gram stain, wet mount and KOH test and others if any Opening Stock Number received in this month Number consumed Damage/Wastage Closing stock Stock sufficient for approximate month Earliest expiry date Quantity This is auto calculated in software. This gives number of STI/RTI drug kits/ reagent/rpr, TPHA test kits available on the first day of the month. Write the number of STI/RTI drug kits/reagent/rpr /TPHA test kits received during the month. Write the number of STI/RTI drug kits/reagent/rpr /TPHA test kits utilised or distributed during the month. Write the number of STI/RTI drug kits/reagent/rpr /TPHA test kits wasted or damaged during the month. This is auto calculated in software. This gives the number of STI/RTI drug kits/reagent/rpr/tpha test kits available on the last day of the month. This is auto calculated in software. (Closing stock/drugs consumed) Every clinic to ensure one quarter (3 months) drug/ testing kits/ reagent supply for the clinic. Write the expiry date of the drug kit, condom or reagent in a lot of the closing stock having the earliest expiry date in MM/YYYY. Write the quantity of the drug kit, condom and reagent kit having earliest expiry date. Section 8: Details of staff at the STI/RTI clinics Should be filled by all STI/RTI clinics Contains human resource details at STI/RTI clinics Medical Officer/s Staff Nurse Number of doctors posts sanctioned, Number in place Number of the doctors trained in STI as per National guidelines (Induction/Refresher/Other) during the month. Number of Staff Nurse posts sanctioned, Number in place Number of the staff nurse trained in STI as per National guidelines (Induction/Refresher/Other) during the month. 15

16 Lab Technician Counsellor Number of Lab Technician posts sanctioned, Number in place Number of the Lab Technician trained in STI as per National guidelines (Induction/Refresher/Other) during the month. Number of Counsellor posts sanctioned, Number in place Number of the Counsellor trained in STI as per National guidelines (Induction/Refresher/Other) during the month. 16

17 Simplified STI/RTI Monthly reporting format for Standalone ICTC/ Public sectors like ESIC, Railways, Defence, Public Sector Undertakings/ Private sector Unique ID. No. SIMPLIFIED STI/RTI MONTHLY REPORTING FORMAT FOR PUBLIC/PRIVATE SECTOR HEALTH FACILITIES Name of Sector and Facility Reporting Period : Month(MM) : Year(YYYY) : Name of Officer In-charge: Phone no. of Officer In Charge: Section 1 : No. of patients Availed STI/RTI services in this month Total Male Female Total No. of patients diagnosed and treated for various STI/RTI Section 2 : Syndromic diagnosis and investigation details (Should be filled by Officer in-charge) Diagnosis Male Female Total 1. Vaginal/Cervical Discharge 2. Genital Ulcer (GUD)-non herpetic 3. Genital ulcer(gud) herpetic 4. Lower abdominal pain(lap) 5. Urethral discharge(ud) 6. Ano-rectal discharge (ARD) 7. Inguinal Bubo(IB) 8. Painful scrotal swelling (SS) 9. Genital warts 10. Other STIs 11. Serologically +ve for syphilis Investigations 12. Number of STI/RTI patients tested for syphilis (RPR/VDRL) 13. Of Above, Number of STI/RTI patients found reactive for syphilis 14. Number of STI/RTI patients referred for HIV testing 15. Of above, Number of STI/RTI patients found HIV reactive 16. Number of STI/RTI patient tested for wet mount 17. Of above, Number of STI/RTI patients found Trichomoniasis positive Section 3. Details of syphilis screening of Pregnant women Service Male Female Total 1. Number of Pregnant women screened for syphilis (VDRL/RPR test) 2. Of above, Number of Pregnant women found reactive 17

18 Prepacked STI Kit 1 Prepacked STI Kit 2 Prepacked STI Kit 3 Prepacked STI Kit 4 Prepacked STI Kit 5 Prepacked STI Kit 6 Prepacked STI Kit 7 RPR/VDRL tests kits Section 4 : Status of Drugs & test kits Drugs & test kits No. of kits Available Guidelines for filling Simplified STI/RTI Monthly reporting format for Standalone ICTC/ Public sectors like ESIC, Railways, Defence, Public Sector Undertakings/ Private sector Who should fill this? This reporting format should be filled and submitted to the corresponding reporting authority (respective SACS or any other corresponding reporting authority) by the 5th of next month by all facilities (standalone ICTC/ Public sectors like ESIC, Railways, Defence, Public Sector Undertakings/ Private sector) NOT supported by NACO as Designated STI/RTI clinics under STI/RTI control and prevention program. In case a sector is reporting data from more than one facility, the individual reports are to be consolidated by the facility/ sector and submitted as one report to SACS every month by the 7th of the month. Note: All facilities supported by NACO as Designated STI/RTI clinics and TI NGOs need to report on the three page STI/RTI format only What are the different sections of STI format? The STI format is divided into 4 sections as follows: Section 1: Number of Patients availed STI/RTI services in this month Section 2: Syndromic diagnosis and investigation details Section 3: Details of syphilis screening of pregnant women Section 4: Status of Drugs & test kits Unique ID of District Name of the facility/ sector Write the Unique ID which will be provided by respective SACS Write the Name of the facility/ sector sending the report. For example, if report is coming from ESIC Karnataka, they will mention All hospitals and dispensaries under ESIC Karnataka For ICTC, they will write name of the facility and the district 18

19 Reporting period Name of the Officer incharge Phone number of the Officer in-charge Reporting month and year in the form of MM and YYYY. Example: the data for the month January, 2012 would be reported in Feb So the reporting month is 01 and year is Name of the medical officer/ nodal officer who is in charge of Clinic/ sector Phone number of the medical officer/ nodal officer who is in charge of Clinic/ sector Section 1: No. of Patients Availed STI/RTI services in this month Fill the number of individuals who have availed STI/RTI services under appropriate sex category No. of patients diagnosed and treated for various STI/RTI Fill the number of individuals visited with any STI/RTI complaints and was treated for the same. Section 2: Syndromic diagnosis and investigation details Diagnosis could be reached on syndromic/clinical/etiological basis Fill up consolidated number of STI/RTI patients diagnosed with following syndromes 1. VCD - Vaginal/Cervical Discharge 2. GUD - Non Herpetic - Genital ulcer disease- Non Herpetic a) Woman with symptomatic vaginal discharge. b) Asymptomatic patient with vaginal discharge seen on speculum examination. c) Cervical discharge seen on speculum examination. (All syndromic, etiological and clinical STI/RTI diagnosis relating to vaginal or cervical discharge should be included here) Female or male or transgender with genital or anorectal ulceration and with NO blisters (vesicles). (All STI syndromic, clinical or etiological diagnosis relating to genial ulcers caused by Treponema Pallidum (syphilis), Haemophilus Ducreyi (Chancroid), Granuloma Inguinale and Lymphogranuloma Venereum (LGV) except herpes simplex virus type 2 should be included here). 19

20 3. GUD - Herpetic - Genital Ulcer Disease Herpetic 4. LAP - Lower Abdominal Pain 5. UD - Urethral Discharge 6. ARD - Ano-Rectal Discharge 7. IB - Inguinal Bubo 8. SS - Painful Scrotal Swelling 9. Genital Warts 10. Other STI's 11. Serologically +ve for Syphilis Investigation details 12. Number of STI/RTI patients tested for syphilis (RPR/VDRL) 13. Of Above, Number of STI/RTI patients found reactive for syphilis 14. Number of STI/RTI patients referred for HIV testing 15. Of above, Number of STI/RTI patients found HIV-infected 16. Number of STI/RTI patient tested for wet mount 17. Of above, Number of STI/RTI patients found Trichomoniasis positive Female or male or transgender with genital or anorectal blisters (vesicles) with ulcers or recurrence primarily caused by herpes simplex virus type 2. Female with lower abdominal pain or tenderness, or cervical motion tenderness. Male or transgender with intact genitalia with urethral discharge with or without dysuria or other symptoms. Male, female or transgender with symptoms of tenesmus or if ano-rectal discharge seen on exam. Individuals with inguinal bubo and NO genital ulcer. (Syndromic or Clinical diagnosis of LGV should be included here) Male or transgender (with intact genitalia) with painful scrotal swelling (primarily caused by infection of Gonococci and Chlamydia) Individuals with anal or genital warts. Individuals attending with any other STI/RTI related condition (e.g. Genital Scabies, pubic lice, and Genital Molluscum Contagiosum etc). Asymptomatic individuals found serologically positive and treated for syphilis. Fill total number of RPR/VDRL tests conducted. Fill the number found reactive in RPR/VDRL test. Fill the number of STI/RTI clinic attendees referred to ICTC. Fill the number detected as HIV reactive, of the referred individuals. Fill in the number of STI/RTI clinic attendees tested with wet mount. Fill the number detected Trichomoniasis positive. 20

21 Section 3: Details of syphilis screening of pregnant women Data should be drawn from the records of ANC clinic in the facility 1. Number of Pregnant women screened for syphilis (VRDL/RPR) 2. Of above, Number of Pregnant women found reactive Write the number of pregnant women undergone RPR/VDRL test for syphilis during the month. Write the number of pregnant women found reactive for RPR/VDRL test. Section 4: Status of Drugs & test kits Provide details of stock status of RPR/VDRL test kits and Pre-packed STI kit 1 to 7 Drugs & test kits available Fill in the numbers of RPR/VDRL test kits and Perpacked STI kit 1, kit 2, kit 3, kit 4, kit 5, kit 6 and kit 7 kits available. 21

22 Reporting Format of Regional STI Training, Research and Reference Laboratories 22 Reporting format for Regional STI Training, Research and Reference Laboratory National AIDS Control Programme Name of centre Address Centre Unique ID Number STI ObGynae Microbiology Community Medicine / Social & Preventive Medicine Name of Faculty In-charge Phone Number- Land Line with STD code Mobile Number Reporting Period: Month (MM) Year (YYYY): Section 1 A: Age & Sex Distribution of STI / RTI patients / samples received (from within State including facilities in the same premises ) Source of Patients/Samples Age Group & Sex Total Up to and Above Male Female TS/TG Male Female TS/TG Male Female TS/TG Male Female TS/TG Male Female TS/TG STI OPD / IPD ObGynae OPD / IPD NGOs Private Sector Others (Specify) Total Section 1 B: Age & Sex Distribution of STI / RTI patients / samples received (from linked States) Age Group & Sex Up to and Above Male Female TS/TG Male Female TS/TG Male Female TS/TG Male Female TS/TG Male Female TS/TG S.No Name of the State Section 2 : Syndromic validation of patients /samples received by centre STI/RTI syndrome Number tested Number found Positive Mention the number No of syndromic Name of Laboratory Test/s performed received Specific STI Male Female TS/TG Total Male Female TS/TG Total diagnosis matched by lab tests Syndrome S.No Dark Field Microscopy VDRL Test - Qualitative VDRL Test - Quantitative ( No of samples showing tit r e s Syphilis GUD Non Herpetic syndrome I 1:8 +ve) RPR Test- Qualitative

23 II III IV V GUD Herpetic syndrome Urethral Discharge syndrome Oral / Anorectal Discharge syndrome Vaginal discharge syndrome Chancroid RPR Test - Quantitative ( No of samples showing titre 1:8 +ve) TPHA test FTA-Abs TP ELISA IgG & IgM Gram stain of ulcer smear Culture Donovanosis Tissue smear for Donovan bodies HSV II N gonorrheae C trachomatis T vaginalis N gonorrheae C trachomatis T vaginalis Candida sp Culture B vaginosis Gram stain Ulcer smear for MNGC IgM Anti HSV ELISA Antigen GC Smear - Male (Discharge/Urine) GC Culture -Male ELISA Antigen DFA Direct wet mount- Discharge Urine sediment Culture GC Smear - Discharge GC Culture ELISA Antigen DFA Direct wet mount - Vaginal discharge Culture KOH Gram stain GC Smear - Female N gonorrhea Cervical GC Culture -Female VI discharge ELISA Antigen C trachomatis syndrome DFA T vaginalis Direct wet mount-discharge VII Hepatitis B HBsAg VIII Hepatitis C Anti HCV IX Others (Specify) Total number of patient/samples screened for syphilis (VDRL qualitative and quantitative tests) other than tested under GUD-NH diagnosis Section 3 : Number of Gonococci cultures and Anti Microbial Resistance studies performed Number of GC cultures performed during the month Cefixime Ceftriaxone Both Susceptible Less Sensitive Resistant 23

24 : STI/RTI 24 Section 4 : Number of other STI/RTI pathogens cultured and Anti Microbial Resistance studies performed Remarks Number found resistant / less sensitive to drugs advised in National guidelines S.No Name of the Organism Number of positive cultures 7 Total Stock Wastage Closing Section 5 Status of kits / Consumables Kits Opening stock Number received this month Number Consumed Damaged/ VDRL Kits RPR Kits TPHA Kits ELISA kits HSV II IgM Ct IgM & IgG Ct Ag Tp ELISA IgG Tp ELISA IgM HBs Ag Anti-HCV Ab Section 6 : AMC Status of Equipments Is AMC contract for equipments active - Y / N If answer is NO, mention since when Section 7 : Details of Trainings conducted Total number of persons trained S.No Particular Number of Induction trainings Number of Refresher trainings 1 Microbiologists 2 Lab Technicians 3 Others 4 Total

25 Section 8 : Details of Syphilis EQAS conducted S.No Particular Number of Serum panels distributed Number of reports received Number of feedback provided Section 9 : Details of STI/ RTI Research work by centre S.No Name of the research work undertaken Current status of implementation Brief description of outcome/results S.No Number of research papers sent for publication Number of papers accepted Number of research papers published* STI / Gynae Community Medicine Microbiolog y Others * Hard Copy of research papers published should be provided to NACO 25

26 Guidelines for filling reporting format for Regional STI Training, Research and Reference Laboratories Who should fill this? This reporting format should be filled by all regional STI training, research, reference laboratories and State STI reference centers and submitted to the corresponding reporting authority through SIMS with a hard and soft copy to Apex Regional STI centre. All centers (regional and state) should fill all sections of the format. What are the different sections of STI format? The format is divided into nine sections as follows: Section 1A: Age and sex distribution of STI/RTI Patients/Samples received from within the state including facilities in the same premises. Section 1B: Age & Sex Distribution of STI/RTI patients/samples received (from linked States) Section 2: Syndromic validation of patients/samples received by centre Section 3: Number of Gonococci cultures and Anti Microbial Resistance studies performed Section 4: Number of other STI/RTI pathogens cultured and Anti Microbial Resistance studies performed Section 5: Status of kits Section 6: AMC Status of Equipments Section 7: Details of Trainings conducted Section 8: Details of Syphilis EQAS conducted Section 9: Details of STI/ RTI Research work by centre Name of centre Address Centre Unique ID Name of the Faculty incharge STI /ObGynae/ Microbiology /Social & Preventive Medicine or Community Medicine Mention the name of the Institute where the regional or state centre is located. Mention the detailed postal address of the centre. Centre Unique ID number will be provided by respective SACS Mention the name of Faculty in charge from each of the four basic specialties (STI/ObGynae/Microbiology/SPM or CM) 26

27 of each of the Faculty in charge - STI /ObGynae / Microbiology / Social & Preventive Medicine or Community Medicine Phone Number- Land Line with STI code Mobile number Reporting period Mention the ID of each of the faculty in charge of STI /ObGynae/Microbiology /Social & Preventive Medicine or Community Medicine Mention the Land Line Phone number with STD code of each of the faculty in charge from STI/ObGynae/Microbiology/Social & Preventive Medicine or Community Medicine Mention the Mobile Phone number of each of the faculty in charge from STI /Gynae/Microbiology/Social & Preventive Medicine or Community Medicine Reporting month and year in the form of MM and YYYY. Example: the data for the month January, 2013 would be reported in Feb So the reporting month is 01 and year is Section 1 A Age and sex distribution of STI/RTI Patients/Samples received from within the state including facilities in the same premises. Fill the number of sample received for laboratory testing from individuals who attended regional STI centre under appropriate age and sex category or sample received for testing at the regional centre from different sources. Please specify source from where patient/sample was received. STI OPD / IPD ObGynae OPD / IPD NGOs Private Sector Others (Specify) STI Out Patient Department (OPD)/ Inpatient department (IPD), Gynaecology and Obstetrics Out Patient Department (OPD)/ Inpatient department (IPD) Non-Government Organizations implementing Targeted Intervention projects Any provider in private sector from any other source/s. Section 1 B Age and sex distribution of STI/RTI Patients/ Samples received from linked States All Regional STI Reference, Training and Research laboratories are linked to state reference centre of other states. Please mention the name of referring state in the column marked Name of State. Fill the number of sample received for laboratory testing from individuals who attended regional STI centre under appropriate age and sex category or sample received for testing at the regional centre. 27

28 Section 2 Syndromic validation of Patient/Sample received by centre. Centre will receive either patient/sample with STI/RTI syndromic diagnosis for laboratory testing. Centre to record, number of such patient/sample received under each syndrome. Centre to perform laboratory test to validate the diagnosed syndrome and record the results as per the sex distribution of patient/sample. For Example: A patient /sample is sent to centre with a diagnosis of Genital Ulcer Disease Non Herpetic Syndrome (GUD-NH Syndrome). The most common etiologic agents for GUD-NH syndrome are T. pallidum (Syphilis); H. ducreii (Chancroid), K. granulomatis (Donovanosis). The centre performs the tests to detect the above etiological agents (Microscopic or serologic) for GUD-NH syndrome. If any or all of the above etiological agents are detected for GUD-NH syndrome, then the centre will report the number of such patients/samples matched with syndromic diagnosis. The results for all other STI/RTI syndromes (GUD-Herpetic syndrome; Urethral Discharge syndrome; Vaginal Discharge syndrome; Cervical Discharge syndrome; Oral/ Ano-Rectal discharge syndrome) to be recorded in a similar manner. Centre to record the number of tests performed for Hepatitis B and Hepatitis C and provide the results. If Centre has performed any other STI/RTI tests then that information should be recorded under Others'. Please specify the etiological agent/s detected. Centre to record the total number of patient/samples screened for syphilis (VDRL qualitative and quantitative tests) during the reporting period other than patients/samples tested under GUD-NH diagnosis Section 3 Number of Gonococci cultures and Anti microbial resistance studies performed. Centre to record the number of gonococcal cultures performed during the month. Centre to record the results of antimicrobial sensitivities results of the gonococci strains cultured for Cefixime, Ceftriaxone and both. Record the number of Gonococci strains found 'Susceptible' 'Less sensitive' 'Resistant' to Cefixime, Ceftriaxone and Both. Section 4 Number of Other STI/RTI pathogen cultured and Anti microbial resistance studies performed. Centre to record the number of other STI/RTI causing agents cultured during the month. Centre to record antimicrobial sensitivities results of the cultured STI/RTI etiologic agents for drugs advised in National STI/RTI treatment guidelines and record number found 'Resistant' and 'Less sensitive' to the drugs. 28

29 Any additional information, which is relevant under this section is to be recorded under Remarks column Section 5 Status of kits Centre to record status of Kits. Centre to mention separately for each of the test kits (VDRL, RPR, TPHA, ELISA, HSV II IgM, Ct IgM and IgG, Ct Ag, TP ELISA IgG & IgM, HbSAg Anti-HCV Kits) Opening stock Number received during this month Number consumed Damage/wastage Closing stock Total number of stock on the first day of the month (Auto generated). Number of kits /consumables received by the centre in the current month Number of kits/consumables utilized during the month Mention the number of kits/consumables damaged/ wastage in the month Opening stock plus number received in the month minus (number consumed plus number damaged/wasted in the month). Section 6 Annual Maintenance Status of equipment. Centre to record Annual Maintenance Contact (AMC) status of equipment. Y for Yes and N for No. If Centre does not have AMC for any equipment mention since when the AMC is not present. Section 7 Details of Trainings conducted. Centre to record details of induction /refresher training conducted for various cadres of staffs (Microbiologists, Laboratory Technicians and Others). Centre to record number of staff trained Section 8 Details of Syphilis EQAS of conducted. Particulars of serum panels distributed Number of reports received Number of feedback provided Number of serum panels distributed by Regional STI centre (from Apex centre to other regional centres and from regional centres to state reference centres) Number of centres provided reports of panel testing (to be recorded by centre which has distributed the panels) Number of centres provided with feedback on panel testing (feedback to be provided by centre which distributed the panels) 29

30 Section 9 Details of STI/RTI research work conducted by the centre. Name of the research work undertaken Current status of implementation Brief description and outcome/results Number of research papers sent for publication by (STI, Gynaecology & Obstetrics, Community Medicine, Microbiology and other departments) Number of papers accepted Number of research papers published Mention the title of the research work undertaken by centre. Mention the progress of the research work undertaken. Mention the outcome /results of the research work undertaken in brief. Mention the number of research papers sent by various departments for publication during the reporting period. Mention the number of research papers accepted for publication during the reporting period. Mention the number of research papers published by peer reviewed journals during the reporting period. 30

31

32 National Aids Control Organisations India s Voice against AIDS Department of AIDS Control Ministry of Health & Family Welfare, Government of India Designed & Produced By Onlineprinters